Latest Articles
-
High Margins, 1.0% Discount: Buy Merck Stock Now
Merck (MRK) stock might be a good buy now. Why? Because you get high margins – reflective of pricing power and cash generation capacity – for a discounted price . Companies like this generate consistent, predictable profits and cash f...
-
Buy or Sell Merck Stock?
Merck (MRK) stock has jumped 10% during the past week, and is currently trading at $104.63. We believe there are only a couple of things to fear in MRK stock given its overall Moderate operating performance and financial condition. This is align...
-
Why Merck Stock Jumped 40%?
Merck (MRK) ’s stock skyrocketed 41%, fueled less by revenue and more by sharper profits and soaring investor confidence. From a pivotal Q3 earnings beat to the FDA nod on Keytruda’s new form and a stellar Wells Fargo upgrade, multiple catalysts ...
-
Merck Stock Now 0.8% Cheaper, Time To Buy
Merck (MRK) stock might be a good buy now. Why? Because you get high margins – reflective of pricing power and cash generation capacity – for a discounted price . Companies like this generate consistent, predictable profits and cash f...
-
Ten-Year Tally: Merck Stock Delivers $91 Bil Gain
In the last decade, Merck (MRK) stock has returned a notable $91 Bil back to its shareholders through cold, hard cash via dividends and buybacks. Let’s look at some numbers and compare how this payout power stacks up against the market̵...
-
Merck Stock Pricing Powerhouse Now 17% Cheaper, Buy?
Merck (MRK) stock deserves your consideration. Why? Because you get monopoly-like high margins for a discounted price . Here is some data. Revenue Growth : Merck saw growth of 1.8% LTM and 3.7% last 3 year average. Recent Profitability : Nearl...
-
High Margins, Lower Price: Is This Merck stock’s Buying Window?
Merck (MRK) stock deserves your consideration. Why? Because you get monopoly-like high margins for a discounted price . Here is some data. Revenue Growth : Merck saw growth of 1.8% LTM and 3.7% last 3 year average. Recent Profitability : Nearl...
-
MRK Up 7.4% in One Day, Should You Buy The Stock?
We believe there is a near-equal mix of good and bad in MRK stock given its overall Moderate operating performance and financial condition. This is aligned with the stock’s Moderate valuation because of which we think it is Fairly Priced ....
-
MRK Capital Return Hits $91 Bil in 10 Years
In the last decade, Merck (MRK) has returned a notable $91 Bil back to its shareholders through cold, hard cash via dividends and buybacks. Let’s look at some numbers and compare how this payout power stacks up against the market’s bi...
-
After MRK’s 6.8% Climb in a Day, INVA Looks Like the Stronger Long-Term Play
Innoviva (INVA) offers superior revenue growth across key periods, better profitability, and relatively lower valuation vs Merck (MRK), suggesting you may be better off investing in INVA INVA’s quarterly revenue growth was 0.4%, vs. MRK&#...
-
S&P 500 Movers | Winners: PFE, MRK, DHR | Losers: ALB, MGM, COF
On Tuesday, September 30, a market-wide surge lifted the S&P 500 rising 0.41%, the Dow 30 rising 0.18%, and the Nasdaq 100 rising 0.28%. Gains were broad-based, though not every stock joined the rally. List of S&P 500 Winners ...
-
Better Bet Than Elanco Animal Health Stock: Pay Less To Get More From LLY, MRK
LLY, MRK are ELAN’s peers in Pharmaceuticals industry that have: 1) Lower valuation (P/OpInc) compared to ELAN 2) But higher revenue and operating income growth This disconnect between valuation and performance could mean that you are bet...
-
Ten-Year Tally: MRK Hands Back $89 Bil to Shareholders
In the last decade, Merck (MRK) has returned a notable $89 Bil back to its shareholders through cold, hard cash via dividends and buybacks. Let’s look at some numbers and compare how this payout power stacks up against the market’s bi...
-
MRK Stock Up 6.1% after 6-Day Win Streak
Merck (MRK) stock hit day 6 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 6.1% return. The company has gained about $13 Bil in value over the last 6 days, with its current market capitalization a...
-
MRK Stock Up 5.2% after 5-Day Win Streak
Merck (MRK) stock hit day 5 of a continuous streak of days with gains, with cumulative gains over this period amounting to a 5.2% return. The company has gained about $11 Bil in value over the last 5 days, with its current market capitalization a...
